JD
Desmeules, Jules Alexandre
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Alliance thérapeutique et thérapie cognitivo-comportementale de groupe | Revue médicale suisse | 2023 | 109 | 326 | |||
| Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine | Acta haematologica | 2023 | 69 | 132 | |||
| Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals | 2023 | 67 | 53 | |||
| Thérapie cognitive-comportementale de groupe : quelques éléments cliniques autour des concepts de honte et de culpabilité chez les patients souffrant de douleurs chroniques | Douleur et analgésie | 2023 | 4 | 0 | |||
| Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol | Frontiers in pain research | 2023 | 127 | 263 | |||
| Is massage a legitimate part of nursing care ? A qualitative study | PloS one | 2023 | 76 | 239 | |||
| Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans | Genome biology and evolution | 2022 | 538 | 251 | |||
| Opioid‐related adverse drug reactions in patients visiting the emergency division of a tertiary hospital | Pharmacology research & perspectives | 2022 | 153 | 125 | |||
| Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice? | Frontiers in pediatrics | 2022 | 186 | 202 | |||
| Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy | Thérapie | 2022 | 216 | 0 | |||
| Dexamethasone for the treatment of established postoperative nausea and vomiting: A randomised dose finding trial | European journal of anaesthesiology | 2022 | 372 | 319 | |||
| Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots | Clinical and translational science | 2022 | 245 | 240 | |||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | 2022 | 154 | 134 | |||
| Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways | Frontiers in neuroscience | 2022 | 419 | 189 | |||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | 2022 | 225 | 332 | |||
| Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients | Frontiers in genetics | 2022 | 242 | 219 | |||
| Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients | Frontiers in aging neuroscience | 2022 | 90 | 193 | |||
| Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics | CPT: pharmacometrics & systems pharmacology | 2022 | 301 | 490 | |||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | 2021 | 212 | 216 | |||
| Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients | Drugs | 2021 | 255 | 656 | |||
| Activité, décentration et restructuration cognitive dans la thérapie cognitivocomportementale. Éléments pour la pratique clinique | Revue médicale suisse | 2021 | 396 | 1,421 | |||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | 2021 | 283 | 338 | |||
| Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland | Frontiers in Psychiatry | 2021 | 319 | 515 | |||
| The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker? | Journal of personalized medicine | 2021 | 227 | 67 | |||
| Opioïdes monoaminergiques : lequel choisir ? | Revue médicale suisse | 2021 | 182 | 234 | |||
| Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature | Frontiers in pharmacology | 2021 | 220 | 860 | |||
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | 2021 | 329 | 216 | |||
| Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS | Journal of chromatography. B | 2021 | 435 | 535 | |||
| Impacts of touch massage on the experience of patients with chronic pain: a protocol for a mixed method study | Complementary therapies in clinical practice | 2021 | 290 | 1 | |||
| Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review | Clinical pharmacokinetics | 2021 | 232 | 357 | |||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | 2021 | 184 | 305 | |||
| Cannabinoids and COVID-19 | Medical Cannabis and Cannabinoids | 2020 | 257 | 205 | |||
| Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins | Drug Safety | 2020 | 724 | 432 | |||
| Mise au point sur la prise en charge de la douleur chez les patients adultes atteints de déficience intellectuelle | Douleur et analgésie | 2020 | 63 | 2 | |||
| Outcomes of drug exposition during pregnancy: Analysis from a teratology information service | European Journal of Obstetrics, Gynecology, and Reproductive Biology | 2020 | 278 | 4 | |||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | 2020 | 337 | 566 | |||
| GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers | European Journal of Pain | 2020 | 259 | 1 | |||
| Opioïdes chez les patients âgés: Faux-amis ? | La gazette médicale - info@gériatrie | 2020 | 254 | 1 | |||
| The Role of Demoralization and Meaning in Life (DEMIL) in Influencing Suicidal Ideation Among Patients Affected by Chronic Pain: Protocol of a Single-Center, Observational, Case-Control Study | JMIR Research Protocols | 2020 | 409 | 255 | |||
| Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes | Journal of Neuroscience Research | 2020 | 316 | 2 | |||
| Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerations | European Journal of Pain | 2020 | 290 | 1 | |||
| Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children | Therapeutic Drug Monitoring | 2020 | 452 | 204 | |||
| TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities | BMJ Open | 2020 | 382 | 155 | |||
| Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini Review | Frontiers in Pharmacology | 2020 | 279 | 263 | |||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | 2020 | 358 | 112 | |||
| Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail | Journal of Personalized Medicine | 2019 | 480 | 336 | |||
| Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches | Clinical Pharmacokinetics | 2019 | 426 | 3 | |||
| Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients | PLOS ONE | 2019 | 398 | 312 | |||
| Safety issues of pharmacological acute pain treatment in children | Clinical Pharmacology and Therapeutics | 2019 | 411 | 4 | |||
| A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder | BMC Psychiatry | 2019 | 523 | 1,497 | |||
| Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic Study | Current Analytical Chemistry | 2019 | 476 | 1 | |||
| Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more? | International Journal of Clinical Pharmacy | 2019 | 324 | 500 | |||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | 2019 | 471 | 4 | |||
| Pourquoi proposer la thérapie cognitivo-comportementale dans les douleurs chroniques ? | Revue médicale suisse | 2019 | 495 | 630 | |||
| Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactions | CPT: pharmacometrics & systems pharmacology | 2019 | 412 | 495 | |||
| Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled study | European Journal of Pain | 2019 | 401 | 2 | |||
| Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling | Pediatric Research | 2019 | 336 | 2 | |||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 738 | 853 | |||
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | 2018 | 522 | 940 | |||
| Gestion de la douleur aiguë chez les patients sous traitements de substitution aux opioïdes | Revue médicale suisse | 2018 | 685 | 479 | |||
| Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting | Journal of Clinical Psychiatry | 2018 | 492 | 0 | |||
| Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software | Biopharmaceutics & Drug Disposition | 2018 | 627 | 12 | |||
| Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes | Basic & Clinical Pharmacology & Toxicology | 2018 | 514 | 895 | |||
| When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children | Frontiers in Pharmacology | 2018 | 559 | 668 | |||
| Prescription des opioïdes chez les patients vulnérables : les enfants et les personnes âgées. Recommandations pratiques | Revue médicale suisse | 2018 | 598 | 613 | |||
| Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report | European Journal of Anaesthesiology | 2018 | 447 | 392 | |||
| Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) | BMC Pharmacology & Toxicology | 2017 | 521 | 223 | |||
| Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactions | Clinical Pharmacology and Therapeutics | 2017 | 498 | 5 | |||
| Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases | Journal of pharmaceutical and biomedical analysis | 2017 | 664 | 885 | |||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | 2017 | 664 | 190 | |||
| "Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn | Frontiers in Pharmacology | 2017 | 638 | 246 | |||
| Impact d'une réconciliation médicamenteuse par un pharmacien lors de l'admission dans un service de médecine interne | Le Pharmacien Hospitalier et Clinicien | 2017 | 296 | 263 | |||
| Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane Transporters | Basic & clinical pharmacology & toxicology | 2017 | 545 | 3 | |||
| PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients | BMJ Open | 2017 | 775 | 509 | |||
| Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine | Journal of Pharmaceutical Sciences | 2017 | 494 | 0 | |||
| Meta-xylene: identification of a new antigenic entity in hypersensitivity reactions to local anesthetics | Journal of allergy and clinical immunology. In practice | 2016 | 663 | 1 | |||
| Le coût, ce n'est pas tout…à propos des médicaments génériques | Revue médicale suisse | 2016 | 453 | 3 | |||
| Prescriptions médicamenteuses potentiellement inappropriées en gériatrie: quels outils utiliser pour les détecter? | La Presse médicale | 2016 | 635 | 8 | |||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | 2016 | 510 | 251 | |||
| The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | Neuropharmacology | 2016 | 594 | 327 | |||
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | 2016 | 935 | 283 | |||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 670 | 1,010 | |||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 625 | 0 | |||
| Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells | Fundamental & clinical pharmacology | 2016 | 631 | 21 | |||
| Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study | Clinical therapeutics | 2016 | 557 | 2 | |||
| Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method | Basic & clinical pharmacology & toxicology | 2016 | 682 | 861 | |||
| Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines | Pharmacology research & perspectives | 2016 | 702 | 364 | |||
| A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients | Multiple sclerosis | 2015 | 649 | 1 | |||
| Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription | Current drug metabolism | 2015 | 588 | 3 | |||
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases | 2015 | 706 | 0 | |||
| Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort | PloS one | 2015 | 602 | 313 | |||
| Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements | Clinical therapeutics | 2015 | 720 | 6 | |||
| Assessing the affective load in the narratives of women suffering from fibromyalgia: the clinicians' appraisal | Health expectations | 2015 | 702 | 1 | |||
| P-glycoprotein: a clue to vitamin K antagonist stabilization | Pharmacogenomics | 2015 | 703 | 0 | |||
| A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up | Journal of neuroimmunology | 2015 | 601 | 1 | |||
| Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | 2015 | 646 | 6 | |||
| Prescription d'antidépresseurs dans le traitement de la douleur : rôle de la pharmacogénétique | Revue médicale suisse | 2015 | 570 | 1 | |||
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | 2015 | 694 | 5 | |||
| Use of metamizole in children and the risk of agranulocytosis: Is the benefit worth the risk? | European journal of anaesthesiology | 2015 | 569 | 4 | |||
| Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist | European journal of internal medicine | 2015 | 739 | 6 | |||
| Is pholcodine a dangerous cough suppressant? | European journal of anaesthesiology | 2015 | 630 | 1 | |||
| GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers | Pain | 2015 | 627 | 3 | |||
| Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review | Current drug metabolism | 2014 | 658 | 0 | |||
| Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping Cocktail | Basic & clinical pharmacology & toxicology | 2014 | 651 | 4 | |||
| Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns | Therapeutic drug monitoring | 2014 | 786 | 3 | |||
| Snapshot of Prescribing Practice for Clopidogrel and Esomeprazole Co-Prescription and Cost Evaluation of Guidelines Application | Value in health | 2014 | 518 | 245 | |||
| Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots | Clinical pharmacology and therapeutics | 2014 | 927 | 527 | |||
| Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool | Health and quality of life outcomes | 2014 | 608 | 397 | |||
| Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity | AIDS research and therapy | 2014 | 739 | 968 | |||
| Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model | CPT: pharmacometrics & systems pharmacology | 2014 | 682 | 300 | |||
| Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma | Bioanalysis | 2014 | 769 | 5 | |||
| Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in Fibromyalgia | The journal of pain | 2014 | 735 | 2 | |||
| Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital | European journal of clinical pharmacology | 2013 | 878 | 836 | |||
| Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study | Basic & clinical pharmacology & toxicology | 2013 | 648 | 442 | |||
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | 2013 | 603 | 3 | |||
| Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers | Basic & clinical pharmacology & toxicology | 2013 | 665 | 441 | |||
| Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial | Pain physician | 2013 | 629 | 1,145 | |||
| Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain | Pain physician | 2013 | 796 | 763 | |||
| Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | 2013 | 773 | 998 | |||
| Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment | Pharmacogenomics | 2013 | 692 | 0 | |||
| Primary attributions in women suffering fibromyalgia emphasize the perception of a disruptive onset for a long-lasting pain problem | Journal of psychosomatic research | 2013 | 683 | 972 | |||
| Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study | PloS one | 2013 | 662 | 474 | |||
| Transcriptional regulation of CYP2C19 and its role in altered enzyme activity | Current drug metabolism | 2012 | 611 | 0 | |||
| Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient | AIDS | 2012 | 639 | 648 | |||
| Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism | Health psychology review | 2012 | 829 | 729 | |||
| Quel programme informatique de détection des interactions médicamenteuses néfastes ? | Revue médicale suisse | 2012 | 981 | 1,012 | |||
| Representations of symptom history in women with fibromyalgia vs chronic low back pain: a qualitative study | Pain medicine | 2012 | 701 | 0 | |||
| Effets indésirables des inhibiteurs de la pompe à proton: faut-il craindre de les prescrire au long cours ? | La Revue de médecine interne | 2012 | 770 | 2,135 | |||
| Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | 2012 | 808 | 1,172 | |||
| Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview | Basic & clinical pharmacology & toxicology | 2012 | 657 | 770 | |||
| Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquer | Revue médicale suisse | 2012 | 620 | 0 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 592 | 0 | |||
| Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders | Journal of perinatal medicine | 2012 | 759 | 1,477 | |||
| Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot | Clinical pharmacology and therapeutics | 2012 | 654 | 0 | |||
| Analgesics in patients with hepatic impairment: pharmacology and clinical implications | Drugs | 2012 | 708 | 3 | |||
| Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection | Journal of viral hepatitis | 2012 | 664 | 0 | |||
| A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry | RCM. Rapid communications in mass spectrometry | 2012 | 848 | 930 | |||
| Rotation des opioïdes : de la théorie à la pratique Recommandations interdisciplinaires du réseau douleur des HUG | Revue médicale suisse | 2011 | 740 | 1 | |||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | 2011 | 1,054 | 651 | |||
| Effet placebo analgésique : apport des neurosciences | Revue médicale suisse | 2011 | 657 | 2 | |||
| A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | 2011 | 680 | 0 | |||
| Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients | Metabolism, clinical and experimental | 2011 | 691 | 0 | |||
| Le placebo, un allié mésestimé.. | Revue médicale suisse | 2011 | 772 | 304 | |||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | 2011 | 881 | 8 | |||
| HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Neuropharmacology | 2011 | 820 | 696 | |||
| ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia | Pharmacogenomics | 2011 | 958 | 6 | |||
| Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Journal of pharmaceutical and biomedical analysis | 2011 | 745 | 938 | |||
| Effect of topical morphine (mouthwash) on oral pain due to chemotherapy- and/or radiotherapy-induced mucositis: a randomized double-blinded study | Journal of palliative medicine | 2010 | 775 | 0 | |||
| The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone | British journal of pharmacology | 2010 | 877 | 2 | |||
| Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 675 | 0 | |||
| Is a bird in the hand still worth two in the bush? | European journal of anaesthesiology | 2010 | 537 | 1 | |||
| Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety | British journal of pharmacology | 2010 | 655 | 1 | |||
| Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein | Basic & clinical pharmacology & toxicology | 2009 | 641 | 2 | |||
| Douleurs chroniques et dépression: un aller-retour ? | Revue médicale suisse | 2009 | 694 | 0 | |||
| Modulation cognitive et émotionnelle de la douleur: mécanismes de certaines approches cliniques révélés par les neurosciences | Revue médicale suisse | 2009 | 739 | 12 | |||
| Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | 2009 | 565 | 0 | |||
| The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction | Pharmacogenomics journal | 2009 | 915 | 0 | |||
| Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital | Drug safety | 2009 | 625 | 0 | |||
| P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone | Fundamental & clinical pharmacology | 2009 | 680 | 0 | |||
| Pharmacogenetics of analgesics: toward the individualization of prescription | Pharmacogenomics | 2008 | 573 | 0 | |||
| Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers | Drug metabolism letters | 2008 | 862 | 0 | |||
| Les toxidermies médicamenteuses | Revue médicale suisse | 2008 | 654 | 0 | |||
| New approaches to the pharmacotherapy of neuropathic pain | Expert review of clinical pharmacology | 2008 | 588 | 0 | |||
| La prescription « off-label » | Revue médicale suisse | 2008 | 699 | 0 | |||
| Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein | Current drug metabolism | 2008 | 657 | 4 | |||
| Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial | JAMA | 2008 | 809 | 4 | |||
| Prise en charge médicamenteuse de la douleur neuropathique : quelle place pour les traitements topiques? | Revue médicale suisse | 2008 | 429 | 0 | |||
| Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry | Clinical biochemistry | 2008 | 665 | 0 | |||
| Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique | Clinical biochemistry | 2008 | 661 | 1 | |||
| Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients | Journal of chromatography. B | 2008 | 627 | 4 | |||
| Automédication chez les sans-papiers latino-américains : entre le nécessaire et l'inapproprié | Revue médicale suisse | 2007 | 424 | 0 | |||
| Detecting drug interactions using personal digital assistants in an out-patient clinic | QJM | 2007 | 434 | 255 | |||
| Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology | Expert opinion on drug safety | 2007 | 539 | 817 | |||
| Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach | Journal of chromatography. B | 2007 | 570 | 0 | |||
| Emergency liver transplantation in amodiaquine-induced fulminant hepatitis | The American journal of tropical medicine and hygiene | 2007 | 675 | 385 | |||
| Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study | Clinical therapeutics | 2007 | 771 | 0 | |||
| Effets indésirables des inhibiteurs de la pompe à protons (IPP) | Revue médicale suisse | 2007 | 538 | 0 | |||
| Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique | Revue médicale suisse | 2007 | 411 | 0 | |||
| Patients' representations of antidepressants: a clue to nonadherence? | The Clinical journal of pain | 2007 | 519 | 1 | |||
| Prescription en médecine de premier recours: l'intérêt d'une liste de médicaments | Revue médicale suisse | 2006 | 459 | 0 | |||
| CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis | European journal of clinical pharmacology | 2006 | 664 | 592 | |||
| Entre sel et gènes ou pharmacogénomique des antihypertenseurs | Revue médicale suisse | 2006 | 418 | 0 | |||
| Prise en charge médicamenteuse des troubles psychologiques et comportementaux lies à la démence | Revue médicale suisse | 2006 | 487 | 0 | |||
| Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors | Archives of internal medicine | 2006 | 492 | 446 | |||
| Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleur | Canadian journal of anaesthesia | 2005 | 554 | 509 | |||
| Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasone | European journal of internal medicine | 2005 | 444 | 0 | |||
| Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase» | Revue médicale suisse | 2005 | 388 | 0 | |||
| Le traitement de l'hypertension artérielle : un défi pour le praticien | Revue médicale suisse | 2005 | 475 | 0 | |||
| SIADH consecutive to ciprofloxacin intake | European journal of internal medicine | 2004 | 490 | 2 | |||
| Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management | Annals of the rheumatic diseases | 2004 | 510 | 2 | |||
| Influence du cycle mentruel sur le seuil de la douleur expérimentale | Douleur et analgésie | 2004 | 607 | 1 | |||
| QT interval prolongation in patients on methadone with concomitant drugs | Journal of clinical psychopharmacology | 2004 | 482 | 0 | |||
| Codeine intoxication associated with ultrarapid CYP2D6 metabolism | The New England journal of medicine | 2004 | 562 | 1 | |||
| Neurophysiologic evidence for a central sensitization in patients with fibromyalgia | Arthritis and rheumatism | 2003 | 549 | 881 | |||
| Clinical pharmacology and rationale of analgesic combinations | European journal of anaesthesiology. Supplement | 2003 | 401 | 0 | |||
| Rofecoxib interaction with oral anticoagulant acenocoumarol | European journal of clinical pharmacology | 2003 | 480 | 259 | |||
| Advances with analgesics and NSAIDs for the treatment of spinal disorders | Baillière's best practice & research. Clinical rheumatology | 2002 | 494 | 686 | |||
| Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen | Journal of the American Academy of Dermatology | 2002 | 528 | 0 | |||
| Hepatitis associated with Kava, a herbal remedy for anxiety | BMJ. British medical journal | 2001 | 666 | 471 | |||
| Effet analgesique des opiaces en usage cutane: quelle est leur efficacite? | Thérapie | 2001 | 434 | 0 | |||
| The tramadol option | European journal of pain | 2000 | 457 | 0 | |||
| Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan | The Journal of pharmacology and experimental therapeutics | 1999 | 376 | 287 | |||
| Anaphylactic shock induced by intraurethral use of chlorhexidine | Allergy | 1999 | 423 | 647 | |||
| Use of the label "litigation neurosis" in patients with somatoform pain disorder | General hospital psychiatry | 1998 | 477 | 227 | |||
| Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex | European journal of clinical pharmacology | 1998 | 539 | 0 | |||
| Facteurs associes aux douleurs cancereuses refractaires | Schweizerische medizinische Wochenschrift | 1998 | 456 | 67 | |||
| Sodium stibogluconate (pentostan) overdose in a patient with acquired immunodeficiency syndrome | Therapeutic drug monitoring | 1998 | 458 | 0 | |||
| Influence du sexe sur la plainte douloureuse | Schweizerische medizinische Wochenschrift | 1998 | 442 | 0 | |||
| Influences génétiques et environnementales sur la neuromodulation et l'effet antinociceptif du dextromethorphan | Schweizerische medizinische Wochenschrift | 1998 | 422 | 0 | |||
| Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapine | The annals of pharmacotherapy | 1998 | 452 | 0 | |||
| Pharmacologie du tramadol | Drugs | 1997 | 757 | 2 | |||
| Stereoselective interaction between piroxicam and acenocoumarol | British journal of clinical pharmacology | 1996 | 648 | 7 | |||
| Atteintes hepatiques medicamenteuses, il faut y penser ! | Schweizerische medizinische Wochenschrift | 1996 | 355 | 0 | |||
| Contribution of monoaminergic modulation to the analgesic effect of tramadol | British journal of clinical pharmacology | 1996 | 511 | 340 | |||
| Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy | Pain | 1995 | 438 | 0 | |||
| Influence of the sympathetic nervous system in the development of abnormal pain-related behaviours in a rat model of neuropathic pain | Neuroscience | 1995 | 518 | 464 | |||
| Time-course of nociceptive disorders induced by chronic loose ligatures of the rat sciatic nerve and changes of the acetylcholinesterase transport along the ligated nerve | Pain | 1994 | 506 | 0 | |||
| Facteurs predictifs d'une resistance au traitement des douleurs neuropathiques | Schweizerische medizinische Wochenschrift | 1994 | 411 | 0 | |||
| Arret de travail et comportement-maladie chez des patients souffrant de douleurs chroniques | Schweizerische medizinische Wochenschrift | 1994 | 479 | 0 | |||
| Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats | Pain | 1994 | 425 | 0 | |||
| The pharmacology of tramadol | Drugs | 1994 | 495 | 0 | |||
| Evaluation de la douleur chronique des patients d'age geriatrique | Schweizerische medizinische Wochenschrift | 1994 | 503 | 0 | |||
| Quelle posologie antalgique du paracetamol? | Schweizerische medizinische Wochenschrift | 1994 | 463 | 0 | |||
| Pericardite recidivante induite par la mesalazine (5-ASA) | Thérapie | 1994 | 437 | 0 | |||
| Opposite effects of axon damage on heat shock proteins (hsp 70) and ubiquitin contents in motor neurons of neuropathic rats | Neuroscience letters | 1993 | 432 | 0 | |||
| The highly selective delta agonist BUBU induces an analgesic effect in normal and arthritic rat and this action is not affected by repeated administration of low doses of morphine | Brain research | 1993 | 426 | 109 | |||
| Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain | Pain | 1993 | 421 | 0 | |||
| In vitro forecasting of drugs that may interfere with codeine bioactivation | European journal of drug metabolism and pharmacokinetics | 1992 | 426 | 148 | |||
| Impact of environmental and genetic factors on codeine analgesia | European journal of clinical pharmacology | 1991 | 426 | 0 | |||
| Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI) | Biochemical and biophysical research communications | 1988 | 424 | 556 |
